<![CDATA[ORION GMP CONSULTING LIMITED - News]]>Wed, 29 May 2024 11:35:50 +0000Weebly<![CDATA[Avoiding common pitfalls during tech transfer and process scale-up]]>Tue, 01 Feb 2022 10:40:44 GMThttp://orionconsulting.ie/news/avoiding-common-pitfalls-during-tech-transfer-and-process-scale-up
One of the most make or break points in the product development cycle is the process of completing technology transfer from one site or entity to another.  This is true whether it is scale up from the R&D lab to the industrial plant or moving a process from one CMO to another due to performance or cost concerns.  This is the point where things can go wrong and all the hard work developing a robust dosage form and precise repeatable methods can come undone when scaled up to industrial batches or moved to an inexperienced CMO.   This can then have the knock-on effect of lengthy delays and cost overruns.
The key to effective technical transfer is to clearly map out the transfer process and to carefully select and carry out good due diligence of CMO partners with experience in developing the drug dosage form you are looking to transfer.  This means engaging with CMOs who can leverage pilot scale equipment as part of the qualification to find the optimum processes early in the development life cycle, iron out kinks and plan qualification activities.  It is key to identify these process technologies early and once down selected to then minimise the level of change and added complexity as the development and scale up progresses.  The client and CMO can learn the sensitivity and behavior of the process early and manage or avoid potential pitfalls.
One trap that many companies fall into is poor knowledge sharing and poor communication, often there can be tribal knowledge about the process learned during R&D or at a previous CMO which is not passed on. Thus, the process parameter or IPC that was known to be critical at the earlier stage is not carried forward and the new team loose months troubleshooting what was already well understood by the initial team.   It is no surprise therefore that teamwork and knowledge sharing are very important to a successful transfer.  
Another critical consideration is robust formulation development.  Scale up and process optimisation can improve the performance of a manufacturing process but only if there is a solid foundation and a robust formulation design in the first place. The client and CMO must also complete process qualification to verify that the transferred process is reproducible during industrial scale commercial manufacture.  The key is to ensure that quality has been designed into the process and critical control process parameters and material attributes are identified that control the quality of the product during manufacture rather than just relying on final test results.
Orion Consulting collectively have several decades of experience in the effective development, scale up and optimisation of industrial pharmaceutical processes and in process qualification to achieve consistency and state of the art six sigma processes.  If you are facing a challenging transfer project and you need an expert to guide and oversee your project please get in touch with us.
info@orionconsulting.ie 
+353 (0)7198 10101
 | +44 (0)203 475 0375 
]]>
<![CDATA[The changing face of Vendor management in the Pharmaceutical Industry]]>Sun, 16 Jan 2022 12:49:06 GMThttp://orionconsulting.ie/news/the-changing-face-of-vendor-management-in-the-pharmaceutical-industry
The past couple of years have seen a considerable shift in how we approach planning and executing our vendor management programs. The transition to working remotely in many facets of business life and the normalisation of the use of online meeting platforms to bring together teams that would have previously travelled to meet face to face at business meetings.  This new reality is visible none more so than in how we complete our audit programs.  There are numerous options to conduct audits remotely, and it is essential to have the right tools and prepare for success.  
Picture
Reminiscing from audits in Spain, Italy, Austria and of course the dream team in India!
Selecting the type of Audit
Remote audits may not suit every situation, and the first step is to assess whether an onsite audit is required or if a virtual audit would be appropriate.  The initial assessment of a new critical supplier or facility to determine if the quality management system is adequate and the site capable of manufacturing or storing the product to be supplied may require an in-depth multi-day onsite audit.  The company and its QPs/RPs need to get a feel for the general levels of housekeeping, cleanliness, and maintenance. They must determine if the facility is well designed and laid out and has the capacity to manufacture or hold the volumes required to GMDP standards.  Follow up routine audits of suppliers initially deemed GMP/GDP compliant (with minimal observations from the initial assessment) would be lower risk. In this situation, it would be appropriate to conduct a remote audit.  The most essential tool in determining what type of audit to complete is the periodic audit risk assessment.  The company should assess the risks associated with individual new suppliers through the change control program and determine if an onsite audit or virtual audit should be added to the audit program.  Also, periodically the entire program should be assessed to determine if the types of audits are appropriate and if in-person visits or virtual assessments can be completed.
Tools and audit planning
For each assessment, we must determine how to complete any proposed audits.  If an on-site evaluation is to be carried out, then the audit must be booked months in advance with the site, as it is a more substantial drain on their resources to host an on-site audit.  
For virtual audits, it is critical to plan for success and ensure the site to be audited will have appropriate recording equipment and adequate broadband/Wi-Fi availability to allow the entire site to be visited virtually.  It is also essential to verify with the site to ensure that SOP’s, records, data and other documentation can be shared with the auditor using a secure data sharing program such as OneDrive or SharePoint.   Often suppliers who supply large numbers of customers and who, as a result, have frequent audits will have detailed documentation packs and walkthrough videos prepared that can enhance this process.  This will allow the initial site tour and document reviews to be completed offline and free up the auditees.  The interviews of key personnel and question and answer sessions can then follow this.

Audit Completion
The organisation needs to determine who will conduct the audit or audits, assess their capabilities and approve the individual plans or audit programs.  Also, an evaluation of whether to use their in-house team, QP/RPs or engage outsourced specialist consultants will be required.
Orion Consulting has a panel of highly experienced auditors with many decades of GxP, laboratory, and facility assessment experience. We can work closely to identify the right expert for your audit requirements, whether supplier assessments, storage sites, testing laboratories or internal or external manufacturing sites.
If you need an immediate assessment of your audit program or have a critical or urgent audit that you need to address then, please contact us at info@orionconsulting.ie
]]>
<![CDATA[The importance of the Quality Management System in the healthcare industry.]]>Sun, 09 Jan 2022 16:20:00 GMThttp://orionconsulting.ie/news/the-importance-of-the-quality-management-system-in-the-healthcare-industry
Healthcare companies wishing to apply for new licences or expand into new GxP areas must first ensure that they have a robust Quality Management System (QMS) appropriate for the type of operations prior to changing activities or initiating the licence application process. 
The QMS consists of all of the manuals, policies and procedures required to ensure that regulated processes are carried out in a controlled manner and ensure that the company manufactures high quality, safe and effective products.
​ 

Consistency
The main benefit of designing an effective and comprehensive QMS is that it provides consistency. So that every time a process is completed, it is carried out in the same way and to the same high standards.  This will mean that employees can access the Standard Operating Procedures (SOPs) and get detailed instructions on how to carry out each task without any deviation from the expected highest standards of research, investigation, reporting and documentation.  
Picture
Compliance

 
​An effective QMS will also ensure compliance with the relevant competent authority, notified body or broader corporate standards relating to Good Manufacturing Practice (GMP), ISO13485, or other regulatory standards to be applied.  A good QMS will be written in conjunction with the associated GxP regulations and will utilise industry best practices. 

Continuous Improvement
​A well designed QMS will also include feedback mechanisms to assure continuous improvement. Where deviations occur CAPAs should be implemented to ensure that the identified root causes of issues encountered are eliminated or mitigated as much as possible.  Similarly, effective management review will ensure that the system and processes are regularly reviewed and any identified trends are actioned appropriately.
​  
Improve efficiency, cost and customer satisfaction
Finally, a well-designed quality management system will also complement other business processes and will lead to streamlined and efficient practices.  When developing procedures that meet the regulatory and licensing requirements companies often utilise business excellent best practices to drive efficiency, cost improvement and customer satisfaction.   
  
Orion Consulting has decades of experience in implementing compliant quality management systems that are correctly suited for the GxP type or phase of your products development lifecycle.  So whether it is an initial GCP QMS to allow your products to enter clinical development, or a QMS for a Marketing Authorisation Holder (MAH) and commercial distribution via a WDA, we can assist.  
​To discuss your needs further contact us at info@orionconsulting.ie.
]]>